Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 123 drug design PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


drug design PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

We have 123 drug design PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

PhD saved successfully

PhD scholarship opportunity: Joint Monash-Leipzig PhD Program in Drug design and Discovery

Applications are invited for outstanding candidates to join out joint PhD programme between the School of Chemistry at Monash University (Australia) and the Faculty of Chemistry and Mineralogy at Leipzig University (Germany). Read more

PhD scholarship opportunity: Joint Monash-Leipzig PhD Program in Drug design and Discovery

Applications are invited for outstanding candidates to join out joint PhD programme between the School of Chemistry at Monash University (Australia) and the Faculty of Chemistry and Mineralogy at Leipzig University (Germany). Read more

Small molecule cancer drug discovery targeting resistant disease.

Despite continuous advances in targeted cancer therapy in recent years, there remains a major challenge to combat drug resistance and poor levels of efficacy in areas of unmet medical need. Read more

Structure-based design of allosteric modulators for G protein-coupled receptors using molecular modelling and pharmacology experiments

Almost all physiological processes are regulated through the activation of G protein-coupled receptors (GPCRs). It has become widely accepted that most GPCRs possess binding sites spatially distinct from their natural ligand binding site (orthosteric site), termed as allosteric sites. Read more

Mining the Hippo signalling pathway for novel anti-cancer therapeutics

Candidates are invited to join the Kadri Lab where our research focuses on developing innovative chemical approaches for the discovery of novel therapeutics to address unmet global health needs. Read more

Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implants

One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more

Towards the development of a novel class of broad-spectrum anti-infective drugs

Through exceptionally strong research collaborations at the interface of chemistry, biology, and medicine, we have applied innovative thinking to the field of (Minor Groove Binders) MGBs to develop a novel platform for drug discovery with the potential to treat an impressive range of diseases, including bacterial, fungal, parasitic, and viral infections. Read more

Chemical glycoengineering of therapeutic antibodies

Glycosylation is the most common posttranslational protein modification. Recombinant therapeutic glycoproteins (RTGs) such as monoclonal antibodies (mAbs) are decorated with complex glycans that determine not only their efficacy but also other critical parameters such as in vivo half-life, stability and antigenicity. Read more

Development of long-acting injectable (LAI) drug delivery systems to treat ocular diseases

Delivery of drug molecules to treat visually impairing ocular diseases that originate in the posterior segment of the eye, has been the most challenging task to the pharmaceutical scientists and retinal specialists. Read more

Mechanistic design of effective pharmaceutical cocrystal formulations

It is estimated that more than 70 percent of the compounds in the pharmaceutical pipeline can be poorly water-soluble. Since solid drug forms must dissolve before absorption can occur, strategies to improve drug solubility and dissolution are a continuous need. Read more

Filtering Results